Biologicznie aktywne skladniki zywnosci funkcjonalnej w profilaktyce chorob nowotworowych

• Autorzy: Darewicz M , Dziuba J , Panfil T
• Języki publikacji: PL

Abstrakty

PL

Zastosowanie biologicznie aktywnych substancji w profilaktyce chorób nowotworowych budzi duże zainteresowanie zarówno przemysłu spożywczego, jak i farmaceutycznego. Powiększający się asortyment produktów zaliczanych do żywności funkcjonalnej stwarza szansę świadomego kształtowania diety w aspekcie szeroko rozumianej profilaktyki nowotworowej. W publikacji omówiono niektóre biologicznie aktywne składniki żywności funkcjonalnej, które mogą odgrywać ważną rolę w zmniejszaniu ryzyka powstawania nowotworów.

EN

The application of biologically active components of food for the cancer diseases prevention excite a great interest of food and pharmaceutical industry. The broadening assortment of the functional food products creates a chance for introducing then in diet planning. The biologically active components of functional food can be widely applied as a element of cancer prevention. In the paper bioactive components of functional food, which may play an important role in decreasing of the risk of cancer diseases were described.

Słowa kluczowe

PL

technologia zywnosci; nowotwory; skladniki zywieniowe; choroby czlowieka; zywnosc; zywnosc funkcjonalna; dieta; profilaktyka; aktywnosc biologiczna; zywienie czlowieka

EN

food technology; cancer; nutritional component; human disease; food; functional food; diet; prevention; biological activity; human nutrition

• Wydawca: -
• Czasopismo: Żywność Nauka Technologia Jakość
• Rocznik: 2003
• Tom: 10
• Numer: 4
• Opis fizyczny: s.36-47,tab.,bibliogr.

Twórcy

autor

Darewicz M

• Katedra Biochemii Żywności, Wydział Nauki o Żywności, Uniwersytet Warmińsko - Mazurski w Olsztynie, PI. Cieszyński 1, 10-756 Olsztyn

autor

Dziuba J

• Katedra Biochemii Żywności, Wydział Nauki o Żywności, Uniwersytet Warmińsko - Mazurski w Olsztynie, PI. Cieszyński 1, 10-756 Olsztyn

autor

Panfil T

• Katedra Biochemii Żywności, Wydział Nauki o Żywności, Uniwersytet Warmińsko - Mazurski w Olsztynie, PI. Cieszyński 1, 10-756 Olsztyn

Bibliografia

• [1] Ambrosone C.B., Coles B.F., Freudenheim J.L., Shields P.G.: Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants. J. Nutr., 1999,129, 565-568.
• [2] Arai S., Morinaga Y., Yoshikawa T., Ischiishi E., Kiso Y., Yamazaki M., Morotomi M., Shimizu M., Kuwata T., Kaminogawa S.: Recent trends in functional food science and the industry in Japan. Biosci. Biotechnol. Biochem., 2002, 66 (10), 2017-2029.
• [3] Arai S.: Functional food science in Japan: state of the art. Biofactors, 2000,12, 1-4.
• [4] Bailey G.S., Williams D.E.: Potential mechanisms for food - related carcinogens and anticarcinogens. Food Techn., 1993, 47 (2), 105-118.
• [5] Bellisle F., Diplock A.T., Hornstra G., Koletzko B., Roberfroid M., Salminen S., Saris W.H.M.: Functional food science in Europe-foreword. Brit. J. Nutr., 1998, 80 Suppl. 1, 1-193.
• [6] Bloch A., Thomson C.A.: Position statement of the American Dietetic Association: phytochemicals and functional foods. J. Amer. Diet. Assoc., 1996, 96, 73-82.
• [7] Bramley P.M.: Is lycopene beneficial to human health? Phytochemistry, 2000, 54 (3), 233-236. [8] Chen H.M., Muramoto K., Yamauchi F.: Structural analysis of antioxidative peptides from soybean ꞵ-conglycinin. J. Agric. Food Chem., 1995, 43, 574-578.
• [9] Connor W.E., Bendich A.: Highly unsaturated fatty acids in nutrition and disease prevention. Proceedings of an International Conference, Barcelona, Spain, 4-6 November 1996, Amer. J. Clin. Nutr. 2000, 71 (Suppl. 1).
• [10] Darewicz M.: Wpływ enzymatycznych modyfikacji kazeiny-P na jej strukturę i wybrane właściwości funkcjonalne. Rozprawy i Monografie, UWM, Olsztyn 2002, 48.
• [11] Diplock A.T., Aggett P.J., Ashwell M., Bornet F., Fern E.B., Roberfroid B.M.: Scientific concepts of functional foods in Europe: consensus document. Brit. J. Nutr., 1999, 81 (Suppl. 1), 1-27.
• [12] Diplock A.T., Charleux J.L., Crozier-Willi G.: Functional food science and defense against reactive oxidative species. Brit. J. Nutr., 1998, 80 (Suppl. 1), 77-112.
• [13] Dziuba J., Iwaniak A., Niklewicz M.: Database of protein and bioactive peptides sequences - BIOPEP, 2003, http://www.uwm.edu.pl/biochemia
• [14] Dziuba J., Iwaniak A., Niklewicz M., Minkiewicz P.: Bovine ꞵ-lactoglobulin and other lipocalins and the source of bioactive peptides. Curr. Top. Pept. Prot. Res., 2003 (praca przyjęta do druku).
• [15] Dziuba J., Minkiewicz P., Nałęcz D.: Biologically active peptides from plant and animal proteins. Pol. J. Food Nutr. Sci., 1999, 8 (1), 3-16.
• [16] El-Bayoumy K., Chung F.L., Richie J. Jr., Reddy B.S., Cohen L., Weisburger J., Wynder E.L.: Dietary control of cancer. Proc. Soc. Exp. Biol. Med., 1997, 216 (2), 211-223.
• [17] Fitzpatrick K.C.: Nutraceuticals and functional foods, present opportunities and challenges for industry. Nutr. Business J., 2002,13 (9), 686-687.
• [18] Floch M.H., Hong-Curtiss J.: Probiotics and functional foods in gastrointestinal disorders. Curr. Gastroenerol., 2001, 3, 343-350.
• [19] Galliland S.E.: Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev., 1990,
• 87, 175-188.
• [20] Giovannucci E., Rimm E.B., Liu Y., Stampfer M.J., Willett W.C.: A prospective study of tomato products, lycopene, and prostate cancer risk. J. National Cancer Institute, 2002, 94 (5), 391-398.
• [21] Goldberg I.: Functional foods for health - the current state and future prospects. Vitafoods International Conference, Copenhagen, March 11-13, 1997.
• [22] Greenwald P., Clifford C., Milner J. A.: Diet and cancer prevention. Eur. J. Cane., 2001, 37 (8), 948- 965.
• [23] Halliwell B.: Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radical Research, 1996, 25, 57-74.
• [24] Handelman G.J.: The evolving role of carotenoids in human biochemistry. Nutrition, 2001, 17 (10), 818-822.
• [25] Hecht S.S.: Chemoprevention by phytochemical modifers of carcinogen metabolism. W: Phytochemicals as bioactive agents, eds. Bidlack W.R., Omaye S.T., Meskin M.S., Topham D.K.W., Tech- nomic, Lancaster, 2000, pp. 43-74.
• [26] Hecht S.S.: Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J. Nutr., 1999, 129, 768-774.
• [27] Hennings H., Glick A. B., Greenhalgh D. A., Morgan D. L., Strickland J. E., Tennenbaum T., Yuspa S. H.: Critical aspects of initiation, promotion and progression in multistage epidermal carcinogenesis. Proc. Soc. Exp. Biol. Med., 1993, 202 (1), 1-8.
• [28] Herber S.M., Van Elswyk M.E.: Dietary marine algae promotes efficient deposition of n-3 fatty acids for the production of enriched shell eggs. Poultry-Science, 1996, 75 (12), 1501-1507.
• [29] Hilliam M.: Functional Food - How big is the market?, The World of Food Ingredients, December, 2000, 50.
• [30] Khachik F., Beecher G.R., Smith J.C.: Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J. Cell. Biochem. 1995, 22, 236-246.
• [31] Kontula P.: In vitro and in vivo characterization of potential probiotic lactic acid bacteria and pre- biotic carbohydrates. Finnish J. Dairy Sci., 1999, 54 (1), 1-142.
• [32] Marcrae R., Robinson R.K., Sadler H.J.: Encyclopedia of food science, food technology and nutrition. Academic Press, London 1993.
• [33] Mitscher L.A., Jung M., Shankel D., Dou J.H., Steele L., Pillai S.P.: Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Med. Res. Rev., 1997,17, 327-365.
• [34] Nakamura Y., Murakami A., Ohto Y., Tanaka T., Ohigashi H.: Inhibitor by I’ - acetoxychavicol acetate of interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW 264 cells. Cancer Res., 1998, 58, 4832-4839.
• [35] Nettleton J.A.: Omega 3 fatty acids and health. Chapman & Hall, New York 1995.
• [36] Nomura A., Stemmermann G.N., Chyon P.H., Kato I., Perez-Perez G.I., Blaser M.I.: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New England J. Med., 1991,325 (16), 1132-1136.
• [37] Ohta T., Nakatsugi S., Watanabe K., Kawamori T., Ishikawa F., Morotomi M., Sugie S., Toda T., Sugimura T., Wakabayashi K.: Inhibitory effects of Bifidobacterium-fermented soy milk on 2-amino- l-methyl-6-phenylimidazol[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis, 2000, 21, 937-941.
• [38] Parodi P.W.: A role for milk protein in cancer prevention. Austral. J. Dairy Technol., 1998, 53 (1), 37-47.
• [39] Parodi P.W.: An assessment of the evidence linking calcium and vitamin D to colon cancer prevention. Austral. J. Dairy Technol., 2001, 56 (1), 38-58.
• [40] Parodi P.W.: Health benefits of conjugated linoleic acid. Food Industry J., 2003, 5 (3), 222-259. [41] Poppel G., Berg H.: Vitamins and cancer. Cancer letters, 1997,114, 195-202.
• [42] Schatzkin A.: Dietary change as strategy for preventing cancer. Cancer Metastasis Rev., 1997, 16, 377-392.
• [43] Shamsuddin A.M.: Nonisoflavone soybean anticarcinogens. Inositol phosphates have novel anticancer function. J. Nutr., 1995, 125, 725-732.
• [44] Stark A.H., Madar Z.: Olive oil as a functional food: epidemiology and nutritional approaches. Nutr. Rev., 2002, 6 (60), 170-176.